Oncolytic Viruses for Induction of Anti-Tumor Immunity
Keywords: AdΔ24; GMCSF; ONCOVEX; Oncolytic virotherapy; Oncolytic virus; cancer; cationic liposome encapsulation; cell kill mechanisms; chemotherapy or radiotherapy; granulocyte-macrophage colony-stimulating factor (GMCSF); reverse tolerance; stealthed virus
Document Type: Research Article
Publication date: 2012-07-01
- Current Pharmaceutical Biotechnology aims to cover all the latest and outstanding developments in Pharmaceutical Biotechnology. Each issue of the journal contains a series of timely in-depth reviews written by leaders in the field covering a range of current topics in both pre-clinical and clinical areas of Pharmaceutical Biotechnology. Current Pharmaceutical Biotechnology is an essential journal for academic, clinical, government and pharmaceutical scientists who wish to be kept informed and up-to-date with the latest and most important developments.